The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its “calming agent” action in turning off the body’s inflammatory response and preventing chronic ...
Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions.
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Joseph Pantginis has given his Buy rating due to a combination of factors surrounding Biomea Fusion’s ...